Clinical Trial Update: An Effectiveness and Safety Study of CNTO 1275 in Patients With Active Psoriatic Arthritis [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the effectiveness and safety of CNTO 1275 (ustekinumab) in patients with active psoriatic arthritis; the study is completed and resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriatic Arthritis

Drugs mentioned

• Stelara (ustekinumab)

Snippet

Sponsor: Centocor, Inc. | Conditions: Psoriatic Arthritis | Phase 2 | Status: COMPLETED | Results posted: 2012-09-05